American Vanguard (NYSE:AVD – Free Report) had its target price trimmed by Lake Street Capital from $14.00 to $12.00 in a research note published on Monday morning,Benzinga reports. The firm currently has a buy rating on the basic materials company’s stock.
Separately, Wall Street Zen lowered shares of American Vanguard from a “hold” rating to a “sell” rating in a report on Saturday.
Get Our Latest Research Report on AVD
American Vanguard Stock Down 9.6%
American Vanguard (NYSE:AVD – Get Free Report) last issued its quarterly earnings data on Friday, June 6th. The basic materials company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.21). The firm had revenue of $127.00 million for the quarter, compared to the consensus estimate of $127.00 million. American Vanguard had a negative net margin of 5.22% and a negative return on equity of 3.45%. During the same period last year, the company posted $0.06 earnings per share.
Hedge Funds Weigh In On American Vanguard
Several hedge funds and other institutional investors have recently bought and sold shares of AVD. Ieq Capital LLC purchased a new stake in shares of American Vanguard during the 4th quarter valued at about $54,000. Proficio Capital Partners LLC bought a new position in American Vanguard in the 4th quarter worth $94,000. PNC Financial Services Group Inc. grew its holdings in American Vanguard by 133.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 6,575 shares of the basic materials company’s stock valued at $30,000 after purchasing an additional 3,753 shares during the period. Intech Investment Management LLC purchased a new stake in American Vanguard in the fourth quarter worth about $50,000. Finally, American Century Companies Inc. increased its holdings in American Vanguard by 23.2% in the 4th quarter. American Century Companies Inc. now owns 64,072 shares of the basic materials company’s stock worth $297,000 after acquiring an additional 12,057 shares in the last quarter. Institutional investors own 79.04% of the company’s stock.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Featured Stories
- Five stocks we like better than American Vanguard
- About the Markup Calculator
- Palantir Stock Holds Support, Despite Political Backlash
- How to Invest in Blue Chip Stocks
- 3 Tightly-Held Growth Stocks Set Up for Short Squeezes
- Canadian Penny Stocks: Can They Make You Rich?
- Science Applications International Is a Wicked Hot Buy in June
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.